Surgical Innovations Group plc

As of December 31, 2024, Surgical Innovations Group plc carries a market capitalization of 513.05M, placing it among publicly traded companies globally. Its enterprise value stands at 617.55M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Surgical Innovations Group plc's next confirmed earnings release is scheduled for March 25, 2027.

As of December 31, 2024, Surgical Innovations Group plc has 932.82M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Surgical Innovations Group plc maintains a current ratio of 1.88, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Surgical Innovations Group plc's stock has declined approximately 30.43% over the past 52 weeks. The 50-day moving average sits at 0.42, while the 200-day moving average is 0.45.

As of December 31, 2024, Surgical Innovations Group plc holds 19.50M in cash and equivalents against 124.00M in total debt, resulting in a net debt position of 30.70M. Total book value stands at 854.10M, with working capital of 248.50M providing operational flexibility.

Surgical Innovations Group plc's most recent stock split took place on December 6, 1996 with a 14:27 split ratio.